Advanced search

459 Results

Unlock all the news: Be the first to know and act before the market!

100% Free Registration

Cullinan Therapeutics Provides Corporate Update and Reports First Quarter 2024 Financial Results	05-15	GL
Cullinan Therapeutics, Inc. Announces Board Changes	05-15	CI
Zions Bancorporation N A : 2023 Annual Report Officers & Directors	03-28	PU
Transcript : Freshworks Inc., Q4 2023 Earnings Call, Feb 06, 2024	02-06
Power Nickel : To File Complaint on Widespread Potential Illegal Short Selling of its Shares	11-23	PU
Fusion Pharmaceuticals Inc. Announces Board Changes	23-10-16	CI
Fusion Pharmaceuticals Appoints Life Science Industry Leaders Jeremy Bender, Teresa Bitetti and David Meek to its Board of Directors	23-10-16	PR
International Biotechnology Trust : August 2023	23-09-22	PU
NH TherAguix SAS : appoints Vincent Carrère as Chief Executive Officer	23-09-12	PU
Ipsen : appoints Ivana Magovčević-Liebisch Ph.D., J.D. and Régis Mulot to Executive Leadership Team	23-09-06	PU
Ipsen : to host an Investor Day to highlight its innovative R&D pipeline and provide financial outlook for 2022	23-08-24	PU
Transcript : Mirati Therapeutics, Inc., Q2 2023 Earnings Call, Aug 08, 2023	23-08-08
Mirati Therapeutics Announces Departure of Chief Executive Officer David Meek	23-08-08	PR
Transcript : Pacific Edge Limited - Shareholder/Analyst Call	23-07-26
Mirati Therapeutics Provides Update on Regulatory Review in the European Union of KRAZATI (adagrasib) for the Treatment of Advanced Non-Small Cell Lung Cancer (NSCLC) with a KRAS G12C Mutation	23-07-21	PR
Mirati Therapeutics Appoints Industry Veteran Carol Gallagher, Pharm.D. as New Independent Director	23-06-23	PR
Transcript : Mirati Therapeutics, Inc. Presents at Goldman Sachs 44th Annual Global Healthcare Conference, Jun-15-2023 08:40 AM	23-06-15
Mirati Therapeutics to Participate at the Goldman Sachs 44th Annual Global Healthcare Conference 2023	23-06-01	PR
Transcript : Mirati Therapeutics, Inc., Q1 2023 Earnings Call, May 09, 2023	23-05-09
Corus Entertainment : OH, CANADA! NEW SEASONS OF CANADIAN ORIGINAL DRAMAS FAMILY LAW AND DEPARTURE RETURN, PLUS NEW UNSCRIPTED SERIES SUPERFAN FEATURING SHANIA TWAIN JOIN GLOBAL AND STACKTV’S SUMMER LINEUP	23-05-01	PU
Corus Entertainment : LOST CAR RESCUE SEASON 2 FOLLOWS CLASSIC CAR HUNTERS’ GREATEST ADVENTURE YET, BEGINNING APRIL 19 ON THE HISTORY® CHANNEL AND STACKTV	23-03-07	PU
Transcript : Mirati Therapeutics, Inc. Presents at Cowen 43rd Annual Healthcare Conference, Mar-06-2023 02:10 PM	23-03-06
JetBlue Further Expands Choices For Customers Across the Northeast With New Daily Nonstop Service Out For Sale Starting Today	23-03-01	BU
Transcript : Mirati Therapeutics, Inc., Q4 2022 Earnings Call, Feb 28, 2023	23-02-28
Mirati Therapeutics Reports Fourth Quarter and Full Year 2022 Financial Results and Recent Corporate Updates	23-02-28	PR
Mirati Therapeutics to Participate at the 43rd Annual Cowen Health Care Conference	23-02-21	PR
Transcript : Mirati Therapeutics, Inc. Presents at SVB Securities Global Biopharma Conference, Feb-14-2023 05:00 PM	23-02-14
Transcript : Mirati Therapeutics, Inc. Presents at 41st Annual J.P. Morgan Healthcare Conference, Jan-09-2023 09:00 AM	23-01-09
Mirati Therapeutics to Present at the 41st Annual J.P. Morgan Healthcare Conference	22-12-22	PR
Transcript : Mirati Therapeutics, Inc. - Special Call	22-12-13
Mirati Therapeutics Announces U.S. FDA Accelerated Approval of KRAZATI™ (adagrasib) as a Targeted Treatment Option for Patients with Locally Advanced or Metastatic Non-Small Cell Lung Cancer (NSCLC) with a KRASG12C Mutation	22-12-12	PR
U.S. FDA approves Mirati's lung cancer drug	22-12-12	RE
Transcript : Mirati Therapeutics, Inc. - Special Call	22-12-07
Transcript : Mirati Therapeutics, Inc. Presents at European Society for Medical Oncology Immuno-Oncology Congress (ESMO-IO) 2022, Dec-07-2022 02:15 PM	22-12-07
Mirati to focus adagrasib/Keytruda study in low PDL1 lung cancer patients	22-12-06	RE
Mirati to focus adagrasib/Keytruda study in low PDL1 lung cancer patients	22-12-05	RE
Transcript : Mirati Therapeutics, Inc., Q3 2022 Earnings Call, Nov 08, 2022	22-11-08
Mirati Therapeutics Reports Third Quarter 2022 Financial Results and Recent Corporate Updates	22-11-08	PR
Mirati Therapeutics Appoints Alan Sandler, M.D., as Executive Vice President and Chief Medical Officer, Shares Update to Executive Leadership Team	22-11-08	PR
Mirati Therapeutics, Inc. Announces Management Changes	22-11-08	CI
Transcript : Mirati Therapeutics, Inc. Presents at BofA Securities Precision Oncology Conference, Oct-03-2022 01:10 PM	22-10-03
Transcript : Mirati Therapeutics, Inc. Presents at 2022 Guggenheim Nantucket Therapeutics Conference, Sep-29-2022 10:00 AM	22-09-29
Transcript : Suncorp Group Limited - Shareholder/Analyst Call	22-09-22
Mirati Therapeutics to Participate in Two Upcoming Healthcare Conferences	22-09-22	PR
Transcript : Mirati Therapeutics, Inc. Presents at BofA Securities Global Healthcare Conference 2022, Sep-14-2022 01:10 PM	22-09-14
Mirati Therapeutics to Participate in Two Upcoming Healthcare Conferences	22-08-31	PR
Transcript : Mirati Therapeutics, Inc., Q2 2022 Earnings Call, Aug 03, 2022	22-08-03
Mirati Therapeutics : Reports Second Quarter 2022 Financial Results and Recent Corporate Updates - Form 8-K	22-08-03	PU
Innoviva, Inc. completed the acquisition of the remaining 40% stake in Entasis Therapeutics Holdings Inc. from a group of shareholders.	22-07-10	CI
Transcript : Mirati Therapeutics, Inc. Presents at Goldman Sachs 43rd Annual Global Healthcare Conference, Jun-16-2022 08:00 AM	22-06-16

No results for this search

All transcripts on over 9000 companies, on the day they post their earnings!

Unlock them now!

fermer